Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2025 04:44 ET | Source: Research and Markets

Plaque Psoriasis Market Research 2024-2034: Environmental and Genetic Factors Boost Demand, Investments in Medical R&D Catalyze Innovations

Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis Market by Treatment, by Route of Administration, by End-user, and by Region" report has been added to ResearchAndMarkets.com's...
November 18, 2024 10:55 ET | Source: Research and Markets

Plaque Psoriasis Research Report 2024: 7 Major Market and 61 Additional Country Market Analysis and Sales Forecasts 2020-2030

Dublin, Nov. 18, 2024 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.The analyst estimates that sales...
October 24, 2024 09:57 ET | Source: Research and Markets

Adalimumab (Humira) Biosimilars Pipeline Review 2024: A Recombinant Human IgG1 mAb - Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Adalimumab (Humira) Biosimilars Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides basic information on...
October 24, 2024 09:53 ET | Source: Research and Markets

Ustekinumab (Stelara) Biosimilars Pipeline Review: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Ustekinumab (Stelara) Biosimilars Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic...
September 30, 2024 09:37 ET | Source: Research and Markets

Plaque Psoriasis Drug Forecast and Market Analysis to 2030: Focus on SAR44156, JNJ-2113, sonelokimab, DC-806, orismilast, Piclidenoson, and TAK-279

Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis: Seven-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's offering. This...
September 30, 2024 06:51 ET | Source: Research and Markets

Generalized Pustular Psoriasis (GPP) Clinical Trials Review, 2024: Uncover Key Investment Strategies with Country-Specific Data by Phase, Trial Status, End Points Status and Sponsor Type

Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...
September 26, 2024 04:17 ET | Source: Research and Markets

U.S. Psoriasis Treatment Awareness & Satisfaction Report: A Review of 2023 - Provides Valuable Insights Into Must-Have Patient-Reported Data Points

Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Psoriasis in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...
September 19, 2024 10:21 ET | Source: Research and Markets

Etanercept Biosimilar Insight Market Report 2024: Pipeline Analysis, Therapeutic Assessment, Sales Assessment, Unmet Needs, and Impact of Drugs

Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Etanercept - Biosimilar Insight, 2024" report has been added to ResearchAndMarkets.com's offering.This "Etanercept - Biosimilar Insight, 2024" report...
May 30, 2024 06:13 ET | Source: Research and Markets

Psoriasis Drugs Market (2023-2034) to Grow by $28.85 Billion - Global and Regional Growth Opportunities for Hospital, Retail, and Online Pharmacies with Profiles of the Top 10+ Market Players

Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Global Psoriasis Drugs Market" report has been added to ResearchAndMarkets.com's offering.The global psoriasis drugs market accounted for USD 12.41...
February 28, 2024 11:05 ET | Source: Research and Markets

US HUMIRA Market Projected for Extensive Growth by 2032 in Noninfectious Autoimmune Uveitis Sector

Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "US HUMIRA Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. An insightful analysis...